MultiHance® Image Library Vaneckova et al. 62F Lung Adenocarcinoma
MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Dotarem® (gadoterate meglumine)1
BENEFIT study
Vaneckova et al.
62-year-old woman with lung adenocarcinoma
These are representative images from reference studies; individual results may vary.
Reference: 1. Vaneckova M, Herman M, Smith MP, et al. The benefits of high relaxivity for brain tumor imaging: results of a multicenter intraindividual crossover comparison of gadobenate dimeglumine with gadoterate meglumine (The BENEFIT Study). AJNR Am J Neuroradiol. 2015 Sep;36(9):1589–1598.
More cases that may interest you
